Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging

Pallavi Madhiraju- August 15, 2024 0

Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42 Inc., a US-based company specialising in advanced ... Read More

Nura Bio kicks off Phase 1 clinical trials for SARM1 inhibitor NB-4746

Pallavi Madhiraju- August 25, 2023 0

Nura Bio, a leading biopharmaceutical company specializing in neuroprotective, small molecule therapies, announced today the initiation of Phase 1 clinical trials for its groundbreaking SARM1 ... Read More

ATAI Life Sciences partners with Neuronasal to develop concussion treatment

pharmanewsdaily- January 7, 2020 0

ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild ... Read More